Meta-analysis of randomised trials comparing gemcitabine-based doublets versus gemcitabine alone in patients with advanced and metastatic pancreatic cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/17896834

Download in:

View as

General Info

PMID
17896834